I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 11 studies | 21% ± 6% | |
| ciliated cell | 9 studies | 25% ± 8% | |
| oligodendrocyte | 9 studies | 27% ± 10% | |
| natural killer cell | 7 studies | 19% ± 2% | |
| epithelial cell | 5 studies | 37% ± 12% | |
| fibroblast | 5 studies | 18% ± 3% | |
| macrophage | 5 studies | 19% ± 2% | |
| classical monocyte | 4 studies | 22% ± 6% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 18% ± 1% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 17% ± 2% | |
| basal cell | 4 studies | 25% ± 5% | |
| endothelial cell of lymphatic vessel | 4 studies | 18% ± 1% | |
| naive B cell | 3 studies | 17% ± 2% | |
| hematopoietic precursor cell | 3 studies | 21% ± 4% | |
| B cell | 3 studies | 19% ± 4% | |
| myeloid cell | 3 studies | 22% ± 4% | |
| lymphocyte | 3 studies | 19% ± 5% | |
| secretory cell | 3 studies | 19% ± 4% | |
| glutamatergic neuron | 3 studies | 30% ± 12% | |
| neuron | 3 studies | 26% ± 6% | |
| plasmacytoid dendritic cell | 3 studies | 25% ± 7% | |
| astrocyte | 3 studies | 29% ± 8% |
